The use of clinical trial simulation to support dose selection: application to development of a new treatment for chronic neuropathic pain.
- 1 November 2003
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 20 (11) , 1752-1759
- https://doi.org/10.1023/b:pham.0000003371.32474.ee
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Postmarketing drug dosage changes of 499 FDA‐approved new molecular entities, 1980–1999Pharmacoepidemiology and Drug Safety, 2002
- Changes in prescribed drug doses after market introductionPharmacoepidemiology and Drug Safety, 2002
- Simulation of Clinical TrialsAnnual Review of Pharmacology and Toxicology, 2000
- Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes MellitusA Randomized Controlled TrialJAMA, 1998
- Pharmacokinetics of gabapentin in subjects with various degrees of renal functionClinical Pharmacology & Therapeutics, 1994
- A Saturable Transport Mechanism in the Intestinal Absorption of Gabapentin Is the Underlying Cause of the Lack of Proportionality Between Increasing Dose and Drug Levels in PlasmaPharmaceutical Research, 1993
- Standardization of the rat paw formalin test for the evaluation of analgesicsPsychopharmacology, 1991
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977
- A METHOD FOR MEASUREMENT OF ANALGESIC ACTIVITY ON INFLAMED TISSUE1957